Biofisica, a developer of wound care therapy, has closed on $2 million in venture debt financing from Leader Ventures.
The company plans to use the funds for working capital and operational expenses.
Biofisica is developing a bio-electric stimulation therapy called POSiFECT. It is being sold in the United Kingdom. The product combines moist wound care dressing and electrical stimulation.
Biofisica is seeking U.S. Food and Drug Administration approval to sell the treatment in the U.S.
"We are pleased that Leader Ventures has chosen to support our business model as we move forward with this important product in the field of wound care management," said Rafael Andino, chief executive officer at Biofisica. "This new infusion of capital supports our efforts to establish POSiFECT as a premier product in the wound care market and demonstrates Biofisica’s ability to attract high caliber investment partners."
Leader Ventures has offices in Atlanta, Menlo Park, Calif., and San Francisco.
